{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-154675","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.341860+00:00","generated_at":"2026-06-01T06:13:48.639131+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aileron sets 2024 annual meeting for Aug 20; shareholder proposals due June 15","bullets":["Annual meeting date changed to August 20, 2024, more than 30 days from last year's anniversary.","Deadline for Rule 14a-8 stockholder proposals is June 15, 2024.","Deadline for director nominations under bylaws is also June 15, 2024.","Proposals must comply with bylaws and SEC rules to be considered."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-154675","json":"https://secwatch.observer/filing/0001193125-24-154675.json","markdown":"https://secwatch.observer/filing/0001193125-24-154675.md","text":"https://secwatch.observer/filing/0001193125-24-154675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524154675/0001193125-24-154675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524154675/d839689d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:13:48.639131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}